Results 141 to 150 of about 77,242 (161)

Challenges and opportunities in NASH drug development

Nature Medicine, 2023
Stephen Harrison, Julie Dubourg
exaly  

Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)

Signal Transduction and Targeted Therapy, 2022
Chenyang Zhao
exaly  

Gut bacteria alleviate smoking-related NASH by degrading gut nicotine

Nature, 2022
, Lulu Sun, Yuhong Luo
exaly  

A researcher’s guide to preclinical mouse NASH models

Nature Metabolism, 2022
Suchira Gallage, , Enrico Focaccia
exaly  

Maladaptive regeneration — the reawakening of developmental pathways in NASH and fibrosis

Nature Reviews Gastroenterology and Hepatology, 2020
Changyu Zhu, Ira A Tabas, Robert F Schwabe   +2 more
exaly  

From NASH to HCC: current concepts and future challenges

Nature Reviews Gastroenterology and Hepatology, 2019
Quentin M Anstee, Frcp, Helen L Reeves, Olivier Govaere   +2 more
exaly  

Triggering and resolution of inflammation in NASH

Nature Reviews Gastroenterology and Hepatology, 2018
Daniel Cabrera, Marco Arrese, Ariel E Feldstein   +2 more
exaly  

INTRODUCCIÓN Y EQUILIBRIO DE NASH

2017
openaire   +1 more source

Noninvasive biomarkers in NAFLD and NASH — current progress and future promise

Nature Reviews Gastroenterology and Hepatology, 2018
Vincent Wai-Sun Wong, Victor de Lédinghen, Grace Lai-Hung Wong   +2 more
exaly  

Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

Nature Medicine, 2019
Mohsen Malehmir, Dominik Pfister, Suchira Gallage   +2 more
exaly